Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

A retrospective analysis of the cost of hospitalizations for sickle cell disease with crisis in England, 2010/11.

Pizzo E, Laverty AA, Phekoo KJ, AlJuburi G, Green SA, Bell D, Majeed A.

J Public Health (Oxf). 2015 Sep;37(3):529-39. doi: 10.1093/pubmed/fdu026. Epub 2014 May 5.

PMID:
24796312
2.

Trends in hospital admissions for sickle cell disease in England, 2001/02-2009/10.

Aljuburi G, Laverty AA, Green SA, Phekoo KJ, Banarsee R, Okoye NV, Bell D, Majeed A.

J Public Health (Oxf). 2012 Dec;34(4):570-6. doi: 10.1093/pubmed/fds035. Epub 2012 May 31.

PMID:
22653886
3.

Hospitalisations for sickle-cell disease in an Australian paediatric population.

Teoh Y, Greenway A, Savoia H, Monagle P, Roy J, Barnes C.

J Paediatr Child Health. 2013 Jan;49(1):68-71. doi: 10.1111/jpc.12018. Epub 2012 Dec 2.

PMID:
23198729
4.

Events of hospitalization among children with sickle cell disease.

Fosdal MB, Wojner-Alexandrov AW.

J Pediatr Nurs. 2007 Aug;22(4):342-6.

PMID:
17645962
5.

High resource hospitalizations among children with vaso-occlusive crises in sickle cell disease.

Raphael JL, Mei M, Mueller BU, Giordano T.

Pediatr Blood Cancer. 2012 Apr;58(4):584-90. doi: 10.1002/pbc.23181. Epub 2011 May 16.

PMID:
21584938
6.

National estimates of the inpatient burden of pediatric bipolar disorder in the United States.

Berry EA, Heaton PT, Kelton CM.

J Ment Health Policy Econ. 2011 Sep;14(3):115-23.

PMID:
22116169
7.

Socio-economic deprivation and risk of emergency readmission and inpatient mortality in people with sickle cell disease in England: observational study.

Aljuburi G, Laverty AA, Green SA, Phekoo KJ, Bell D, Majeed A.

J Public Health (Oxf). 2013 Dec;35(4):510-7. doi: 10.1093/pubmed/fdt100. Epub 2013 Oct 29.

PMID:
24169414
8.

The cost of health care for children and adults with sickle cell disease.

Kauf TL, Coates TD, Huazhi L, Mody-Patel N, Hartzema AG.

Am J Hematol. 2009 Jun;84(6):323-7. doi: 10.1002/ajh.21408.

9.

Economic impact of hospitalisations among patients in the last year of life: an observational study.

Gardiner C, Ward S, Gott M, Ingleton C.

Palliat Med. 2014 May;28(5):422-9. doi: 10.1177/0269216313517284. Epub 2013 Dec 23.

PMID:
24367059
10.

Impact of environmental tobacco smoke on children with sickle cell disease.

West DC, Romano PS, Azari R, Rudominer A, Holman M, Sandhu S.

Arch Pediatr Adolesc Med. 2003 Dec;157(12):1197-201.

PMID:
14662575
11.

National trends in hospitalizations for sickle cell disease in the United States following the FDA approval of hydroxyurea, 1998-2008.

Okam MM, Shaykevich S, Ebert BL, Zaslavsky AM, Ayanian JZ.

Med Care. 2014 Jul;52(7):612-8. doi: 10.1097/MLR.0000000000000143.

12.

Age-related treatment patterns in sickle cell disease patients and the associated sickle cell complications and healthcare costs.

Blinder MA, Vekeman F, Sasane M, Trahey A, Paley C, Duh MS.

Pediatr Blood Cancer. 2013 May;60(5):828-35. doi: 10.1002/pbc.24459. Epub 2013 Jan 17.

PMID:
23335275
13.

Mental health disorders influence admission rates for pain in children with sickle cell disease.

Myrvik MP, Burks LM, Hoffman RG, Dasgupta M, Panepinto JA.

Pediatr Blood Cancer. 2013 Jul;60(7):1211-4. doi: 10.1002/pbc.24394. Epub 2012 Nov 14.

PMID:
23151972
14.

Cost of hospitalizations associated with sickle cell disease in the United States.

Davis H, Moore RM Jr, Gergen PJ.

Public Health Rep. 1997 Jan-Feb;112(1):40-3.

15.

Hospital volume, hospital teaching status, patient socioeconomic status, and outcomes in patients hospitalized with sickle cell disease.

McCavit TL, Lin H, Zhang S, Ahn C, Quinn CT, Flores G.

Am J Hematol. 2011 Apr;86(4):377-80. doi: 10.1002/ajh.21977.

16.

Cost-effectiveness of hydroxyurea in reducing the frequency of pain episodes and hospitalization in pediatric sickle cell disease.

Stallworth JR, Jerrell JM, Tripathi A.

Am J Hematol. 2010 Oct;85(10):795-7. doi: 10.1002/ajh.21772.

17.

Ten-year review of hospital admissions among children with sickle cell disease in Kuwait.

Akar NA, Adekile A.

Med Princ Pract. 2008;17(5):404-8. doi: 10.1159/000141506. Epub 2008 Aug 6.

18.

Hydroxyurea is associated with lower costs of care of young children with sickle cell anemia.

Wang WC, Oyeku SO, Luo Z, Boulet SL, Miller ST, Casella JF, Fish B, Thompson BW, Grosse SD; BABY HUG Investigators.

Pediatrics. 2013 Oct;132(4):677-83. doi: 10.1542/peds.2013-0333. Epub 2013 Sep 2.

19.
20.

Hospital utilization patterns and costs for adult sickle cell patients in Illinois.

Woods K, Karrison T, Koshy M, Patel A, Friedmann P, Cassel C.

Public Health Rep. 1997 Jan-Feb;112(1):44-51.

Supplemental Content

Support Center